BALLIET JENNIFER 4
4 · NEOGENOMICS INC · Filed Mar 3, 2021
Insider Transaction Report
Form 4
BALLIET JENNIFER
Vice President of HR
Transactions
- Tax Payment
Common Stock
2021-03-02−173→ 24,595 total - Tax Payment
Common Stock
2021-03-01−212→ 24,768 total - Award
Common Stock
2021-03-02+1,862→ 26,457 total - Award
Stock Option (Right to Buy)
2021-03-02$53.17/sh+10,551$560,997→ 10,551 totalExercise: $53.17Exp: 2028-03-02→ Common Stock (10,551 underlying)
Holdings
- 17,496
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (17,496 underlying) - 7,000
Stock Option (Right to Buy)
Exercise: $7.52Exp: 2022-04-28→ Common Stock (7,000 underlying) - 33,334
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (33,334 underlying) - 15,006
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (15,006 underlying)
Footnotes (7)
- [F1]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock.
- [F2]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock.
- [F3]On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vested ratably over the first three anniversaries of the grant date.
- [F4]On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F5]On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F6]On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F7]On March 2, 2021, Ms. Balliet was granted 10,551 stock options. These options vest ratably over the first four anniversary dates of the grant date.